Search

Drug Profiles Catalysts Company Profiles Impact Events Target
Indication Trials KOL Insight Special Reports All

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
3/31/15 Dyax (DYAX) DX-2930 for Hereditary Angioedema (HAE) Subscribers Only Subscribers Only Subscribers Only
3/31/15 Biotie (BTH1V:FH) BTT-1023 for Primary Sclerosing Cholangitis (PSC) Subscribers Only Subscribers Only Subscribers Only
3/31/15 PAION (PA8G:GR) Remimazolam for Anesthesia Subscribers Only Subscribers Only Subscribers Only
3/31/15 RedHill Biopharma (RDHL) ABC-294640 for Diffuse Large B-cell Lymphoma (DLBCL) - NHL Subscribers Only Subscribers Only Subscribers Only
3/31/15 Neurotech Pharmaceuticals NT-503 for Wet Age-Related Macular Degeneration (Wet AMD) (Ophthalmology) Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
03/31/15 Subscribers Only Subscribers Only Regulatory - PDUFA/Approval Decision (US)
03/31/15 Subscribers Only Subscribers Only Company - Earnings Announcement
03/31/15 Subscribers Only Subscribers Only Company - Earnings Announcement
04/01/15 Subscribers Only Subscribers Only Trial Announcement - Initiation
04/01/15 Subscribers Only Subscribers Only Company - Earnings Announcement